Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685

NCT05332704 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: ONO-4685
DRUG: Placebo
DRUG: ONO-4685
DRUG: Placebo
DRUG: ONO-4685
DRUG: Placebo

Sponsor

Ono Pharmaceutical Co., Ltd.